Abstract | OBJECTIVE: METHODS: A mammalian E1A-expressing recombinant constructed in our laboratory, named pcDNA3-E1A, was introduced into human lung adenocarcinoma cell line(Anip 973) by lipofectamine. The cells resistant to G418 were selected. The characteristics of the E1A-expressing Anip 973(Anip 973-E1A) cells were studied in vitro and in vivo, including cell growth rate and doubling-time, colony-forming efficiency on soft agarose, tumorigenicity and metastasis. RESULTS: The growth rate of E1A-Anip 973 cells was diminished and their colony-forming efficiency was inhibited significantly. The tumorigenicity in nude mice of the E1A-expressing Anip 973 was markedly suppressed. CONCLUSION: E1A suppresses the malignant phenotype of human lung adenocarcinoma cell line. This study provides experimental data for gene therapy of lung cancer with E1A.
|
Authors | X Qian, Q Zhao, Z Wang |
Journal | Zhonghua zhong liu za zhi [Chinese journal of oncology]
(Zhonghua Zhong Liu Za Zhi)
Vol. 22
Issue 5
Pg. 374-6
(Sep 2000)
ISSN: 0253-3766 [Print] China |
PMID | 11778271
(Publication Type: English Abstract, Journal Article)
|
Chemical References |
|
Topics |
- Adenocarcinoma
(secondary)
- Adenovirus E1A Proteins
(genetics, therapeutic use)
- Animals
- Cell Division
(drug effects)
- Disease Models, Animal
- Female
- Genetic Therapy
- Humans
- Immunohistochemistry
- Lung Neoplasms
(pathology, prevention & control)
- Mice
- Mice, Inbred BALB C
- Mice, Nude
- Neoplasm Metastasis
- Neoplasm Transplantation
- Neoplasms, Experimental
(pathology, prevention & control)
- Transfection
- Xenograft Model Antitumor Assays
|